Attention-deficit hyperactivity disorder medication use in pregnancy and risk of miscarriage
ADHD medication use during pregnancy is associated with increased miscarriage risk. However, filled prescriptions may not reflect actual use. Further research is needed to clarify these associations and refine risk estimates.
Authors
- Chaitra Srinivas (ORCID: https://orcid.org/0000-0002-5928-2108)
- Jennifer A. Hutcheon (ORCID: https://orcid.org/0000-0003-0502-3423)
- Kari Furu (ORCID: https://orcid.org/0000-0003-2245-0179)
- Jacqueline M. Cohen (ORCID: https://orcid.org/0000-0002-7300-0488)
- Johan Reutfors (ORCID: https://orcid.org/0000-0003-1372-4262)
- Vidar Hjellvik (ORCID: https://orcid.org/0000-0002-2379-9906)
- Carolyn E. Cesta (ORCID: https://orcid.org/0000-0001-5759-9366)
- Øystein Karlstad (ORCID: https://orcid.org/0000-0003-1204-787X)
- Hein Stigum
Institutions
- Norwegian Institute of Public Health (NO)
- University of British Columbia (CA)
- University of Oslo (NO)
- Society for Maternal-Fetal Medicine (US)
- Karolinska Institutet (SE)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1192/bjp.2025.10467
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 0.00